Cargando…
Hydroxychloroquine for COVID-19: Balancing contrasting claims
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682326/ https://www.ncbi.nlm.nih.gov/pubmed/33243609 http://dx.doi.org/10.1016/j.ejim.2020.11.018 |
| _version_ | 1783612675774742528 |
|---|---|
| author | Horby, Peter W. Emberson, Jonathan R. |
| author_facet | Horby, Peter W. Emberson, Jonathan R. |
| author_sort | Horby, Peter W. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7682326 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76823262020-11-24 Hydroxychloroquine for COVID-19: Balancing contrasting claims Horby, Peter W. Emberson, Jonathan R. Eur J Intern Med Commentary Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. 2020-12 2020-11-23 /pmc/articles/PMC7682326/ /pubmed/33243609 http://dx.doi.org/10.1016/j.ejim.2020.11.018 Text en © 2020 Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Horby, Peter W. Emberson, Jonathan R. Hydroxychloroquine for COVID-19: Balancing contrasting claims |
| title | Hydroxychloroquine for COVID-19: Balancing contrasting claims |
| title_full | Hydroxychloroquine for COVID-19: Balancing contrasting claims |
| title_fullStr | Hydroxychloroquine for COVID-19: Balancing contrasting claims |
| title_full_unstemmed | Hydroxychloroquine for COVID-19: Balancing contrasting claims |
| title_short | Hydroxychloroquine for COVID-19: Balancing contrasting claims |
| title_sort | hydroxychloroquine for covid-19: balancing contrasting claims |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682326/ https://www.ncbi.nlm.nih.gov/pubmed/33243609 http://dx.doi.org/10.1016/j.ejim.2020.11.018 |
| work_keys_str_mv | AT horbypeterw hydroxychloroquineforcovid19balancingcontrastingclaims AT embersonjonathanr hydroxychloroquineforcovid19balancingcontrastingclaims |